MariMed Inc. (MRMD)
OTCMKTS
· Delayed Price · Currency is USD
0.0740
-0.0050 (-6.33%)
May 23, 2025, 3:56 PM EDT
MariMed Revenue
MariMed had revenue of $37.96M in the quarter ending March 31, 2025, with 0.06% growth. This brings the company's revenue in the last twelve months to $157.99M, up 3.84% year-over-year. In the year 2024, MariMed had annual revenue of $157.96M with 6.30% growth.
Revenue (ttm)
157.99M
Revenue Growth
+3.84%
P/S Ratio
0.18
Revenue / Employee
204.12K
Employees
832
Market Cap
28.80M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
BioStem Technologies | 332.45M |
MariMed News
- 16 days ago - MariMed Inc. (MRMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Cannabis Earnings Show Market Split: US Plant-Touching Stocks Drop, IIPR And Cronos Up - Benzinga
- 17 days ago - MariMed Reports First Quarter 2025 Earnings - GlobeNewsWire
- 18 days ago - MariMed Q1 2025 Earnings Preview - Seeking Alpha
- 5 weeks ago - Cannabis Stock Gainers And Losers From April 14, 2025 - Benzinga
- 6 weeks ago - MariMed Announces First Quarter 2025 Earnings Date - GlobeNewsWire
- 6 weeks ago - MariMed Promotes Ryan Crandall to Chief Commercial Officer - GlobeNewsWire
- 7 weeks ago - Cannabis Stock Movers For April 3, 2025 - Benzinga